v3.25.4
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net loss $ (7,567,606) $ (12,369,252)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 1,513,550 4,500,178
Change in fair value of notes 114,704
Loss on extinguishment of debt 394,257
Deferred Revenue 500,000
Other Expense 91,991
Changes in assets and liabilities:    
Prepaid and other current assets 594,238 (1,278,185)
Accounts receivable (500,000)
Accounts payable 1,315,506 1,289,488
Accounts payable - related party (20,000)
Accrued expenses (858,888) (874,411)
Net cash used in operating activities (5,003,200) (8,151,230)
Cash flows from financing activities    
Proceeds from issuance of common stock and warrants, net of fees 752,692 3,200,000
Proceeds from issuance of convertible promissory notes and warrants (503,696)
Proceeds from the issuance of common stock in connection with equity purchase agreement 5,565,916
Payment of costs from issuance of common stock and warrants
Payment of costs in connection with equity purchase agreement (195,997)
Repayment of convertible promissory notes (559,600)
Settlement of shares withheld for payment of employee taxes (15,279) (104,319)
Net cash provided by financing activities 737,413 7,402,304
Net change in cash (4,265,787) (748,926)
Cash, beginning of period 4,710,642 1,901,887
Cash, end of period 444,855 1,152,961
Non-cash financing activities:    
Common stock issued in connection with conversion of notes payable 445,167
Reclassification of shares settled liability 160,949
Unpaid deferred offering costs and financing fees $ 20,393